v3.26.1
Summary of Significant Accounting Policies - Narrative (Details) - USD ($)
 3 Months Ended 12 Months Ended
Oct. 20, 2025
Sep. 03, 2025
Jul. 19, 2024
May 29, 2024
Mar. 31, 2023
Jul. 13, 2022
Mar. 31, 2026
Dec. 31, 2025
Mar. 31, 2025
Dec. 31, 2025
Jan. 01, 2026
Dec. 30, 2025
Feb. 10, 2025
Product Information [Line Items]                          
Cash and cash equivalents             $ 35,675,081 $ 51,018,657 $ 79,007,535 $ 51,018,657      
Working Capital             60,949,080            
Net loss             14,763,131   9,405,315        
Assets             209,226,863 217,103,012 430,792,998 217,103,012      
Liabilities             98,016,472 91,231,675   91,231,675      
Noncontrolling interests             21,101,478 18,140,502   18,140,502      
Cumulative translation adjustments             (67,516)   495,538        
Cash balances             1,474,896 $ 1,788,119   $ 1,788,119      
Sales and maturities of marketable securities             15,499,834   0        
Net realized gain (loss)             7,112   0        
Contingent consideration, current                       $ 2,740,000  
Loss on change in fair value of contingent consideration             2,760,000   0        
Payment for contingent consideration             $ 0   265,538        
Common stock, par value (in dollars per share)             $ 0.0001 $ 0.0001   $ 0.0001      
Impairment of intangible assets, finite-lived                   $ 8,020,343      
Impairment of intangible assets               $ 22,627,902   30,648,245      
Impairment losses on equity investments without readily determinable fair value               5,000,000   5,000,000      
Accounts receivable, allowance             $ 8,503,759 8,299,053   8,299,053 $ 8,299,053    
Additional provision for credit losses             1,727,270            
Accounts receivable, allowance for credit loss, writeoff             $ (1,522,564)            
Lease term (in years)             10 years            
Maximum                          
Product Information [Line Items]                          
Sublease term (in years)             3 years            
Rapid Temps Reporting Unit                          
Product Information [Line Items]                          
Goodwill, impairment loss                   8,718,398      
Several Reporting Units                          
Product Information [Line Items]                          
Goodwill, impairment loss                   49,509,698      
Exceptional Medical Transportation LLC                          
Product Information [Line Items]                          
Contingent consideration, current           $ 2,000,000 $ 0 0   0      
Contingent consideration period           2 years              
Loss on change in fair value of contingent consideration             0   0        
Payment for contingent consideration                 265,538        
Voting interest           100.00%              
PCA                          
Product Information [Line Items]                          
Contingent consideration, current         $ 15,822,190   5,076,592 5,076,592   5,076,592      
Contingent consideration period         36 months                
Loss on change in fair value of contingent consideration             0   0        
Payment for contingent consideration       $ 1,000,000                  
Contingent consideration period to purchase remaining voting interest         49.00%                
Business acquisition, equity interest issued     $ 1,814,345                    
Common stock, par value (in dollars per share)     $ 0.0001                    
Business acquisition, equity interest issued (in shares)     578,350                    
Voting interest   16.30%     51.00%                
PCA | True-Up Payment                          
Product Information [Line Items]                          
Contingent consideration, current         $ 2,088,243                
PCA | Earn Out Payment                          
Product Information [Line Items]                          
Contingent consideration, current         $ 13,733,947                
Loss on change in fair value of contingent consideration   $ 196,488                      
Payment for contingent consideration   $ 1,687,134                      
Professional Technicians, LLC                          
Product Information [Line Items]                          
Contingent consideration, current             300,000 240,000   240,000     $ 240,000
Loss on change in fair value of contingent consideration             60,000   0        
Voting interest                         100.00%
SteadyMD                          
Product Information [Line Items]                          
Contingent consideration, current $ 2,300,000           5,000,000 2,300,000   2,300,000      
Contingent consideration period 12 months                        
Loss on change in fair value of contingent consideration             2,700,000   0        
Voting interest 100.00%                        
Primary Care Ambulance Corporation                          
Product Information [Line Items]                          
Contingent consideration, current             200,000 200,000   $ 200,000   $ 200,000  
Loss on change in fair value of contingent consideration             $ 0   $ 0        
Voting interest                       100.00%  
Cost of Goods and Service, Product and Service Benchmark | Supplier Concentration Risk | Vendor One                          
Product Information [Line Items]                          
Concentration risk                 20.00%        
Customer One | Revenue Benchmark | Customer Concentration Risk                          
Product Information [Line Items]                          
Concentration risk             10.00%   47.00%        
Customer One | Accounts Receivable | Customer Concentration Risk                          
Product Information [Line Items]                          
Concentration risk             23.00%     23.00%      
Customer Two | Revenue Benchmark | Customer Concentration Risk                          
Product Information [Line Items]                          
Concentration risk             10.00%            
Customer Two | Accounts Receivable | Customer Concentration Risk                          
Product Information [Line Items]                          
Concentration risk             10.00%     12.00%      
Variable Interest Entity, Not Primary Beneficiary                          
Product Information [Line Items]                          
Net loss             $ 1,767,756   $ 1,711,511        
Assets             10,270,219 7,039,301   $ 7,039,301      
Liabilities             22,781,072 17,782,198   17,782,198      
Noncontrolling interests             $ 12,510,853 $ 10,742,897   $ 10,742,897